Inactive Instrument
Precision Therapeutics Inc Share Price Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 9.27Cr 8.3Cr 7.64Cr 6.92Cr 13Cr 880.47Cr 13Cr 91Cr 37Cr 463.15Cr 35Cr 34Cr 1.46TCr | P/E 2026 * |
-4.6x | P/E 2027 * | -72.7x |
|---|---|---|---|---|---|
| Enterprise Value | 9.27Cr 8.3Cr 7.64Cr 6.92Cr 13Cr 880.47Cr 13Cr 91Cr 37Cr 463.15Cr 35Cr 34Cr 1.46TCr | EV / Sales 2026 * |
1.54x | EV / Sales 2027 * | 0.21x |
| Free-Float |
93.93% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/02/2026 | |
| Director of Finance/CFO | - | 16/04/2026 | |
Kyle Okamoto
PSD | President | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 19/02/2020 |
Charles Nuzum
CHM | Chairman | 78 | 09/02/2026 |
| Director/Board Member | 60 | 09/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 9.27Cr | ||
| -0.62% | -1.87% | +46.31% | +56.99% | 6.38TCr | ||
| +0.35% | +3.20% | +14.92% | +84.55% | 5.64TCr | ||
| +0.53% | +1.96% | +15.37% | +106.81% | 5.46TCr | ||
| -2.81% | -4.31% | +23.50% | +50.90% | 4.41TCr | ||
| -0.33% | -1.93% | +20.15% | +98.45% | 4.21TCr | ||
| +0.55% | +2.31% | +224.97% | +942.56% | 4.1TCr | ||
| +3.27% | +47.96% | +112.67% | +96.48% | 3.49TCr | ||
| +1.22% | -1.44% | +14.89% | +47.15% | 3.28TCr | ||
| +0.89% | +20.55% | -42.03% | +373.03% | 2.47TCr | ||
| Average | -0.45% | +7.54% | +47.86% | +206.32% | 4.38TCr | |
| Weighted average by Cap. | +0.18% | +5.44% | +48.50% | +186.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.04Cr 5.41Cr 4.98Cr 4.51Cr 8.43Cr 573.5Cr 8.59Cr 59Cr 24Cr 301.68Cr 23Cr 22Cr 951.38Cr | 43Cr 39Cr 36Cr 32Cr 60Cr 4.1TCr 61Cr 423.71Cr 170.09Cr 2.15TCr 161.86Cr 158.42Cr 6.79TCr |
| Net income | -4.14Cr -3.71Cr -3.41Cr -3.09Cr -5.78Cr -393.1Cr -5.88Cr -41Cr -16Cr -206.78Cr -16Cr -15Cr -652.11Cr | -45L -40.3L -37.07L -33.59L -62.79L -43Cr -63.96L -4.42Cr -1.77Cr -22Cr -1.69Cr -1.65Cr -71Cr |
| Net Debt | - | - |
Employees
-
















